Zai Lab Ltd. Files 8-K: Material Agreement and Financial Obligations

Ticker: ZLAB · Form: 8-K · Filed: Jan 3, 2025 · CIK: 1704292

Zai Lab Ltd 8-K Filing Summary
FieldDetail
CompanyZai Lab Ltd (ZLAB)
Form Type8-K
Filed DateJan 3, 2025
Risk Levelmedium
Pages3
Reading Time4 min
Key Dollar Amounts$0.000006, $41.1 million, $137.0 million, $205.5 million
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, financial-obligation

TL;DR

Zai Lab signed a big deal and has new financial obligations. Keep an eye on this.

AI Summary

On January 2, 2025, Zai Lab Ltd. entered into a material definitive agreement. This filing also indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement for the registrant. The filing includes financial statements and exhibits.

Why It Matters

This 8-K filing signals a significant new agreement and potential financial commitments for Zai Lab Ltd., which could impact its future financial health and strategic direction.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement and new financial obligations, which inherently carry some level of risk and require further investigation into the specifics.

Key Players & Entities

  • Zai Lab Ltd. (company) — Registrant
  • January 2, 2025 (date) — Date of earliest event reported

FAQ

What is the nature of the material definitive agreement entered into by Zai Lab Ltd. on January 2, 2025?

The filing does not specify the details of the material definitive agreement, only that one was entered into on January 2, 2025.

What type of financial obligation has Zai Lab Ltd. created?

The filing states the creation of a 'Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement' but does not provide specific details.

What is the filing date of this 8-K report?

The filing date is January 3, 2025.

Where is Zai Lab Ltd. headquartered?

Zai Lab Ltd. is headquartered in Shanghai, China, with its business address at 4560 Jinke Road, Bldg. 1, Fourth Floor, Pudong, Shanghai, China.

What is Zai Lab Ltd.'s Standard Industrial Classification (SIC) code?

Zai Lab Ltd.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 925 words · 4 min read · ~3 pages · Grade level 11.1 · Accepted 2025-01-03 16:17:05

Key Financial Figures

  • $0.000006 — resenting 10 Ordinary Shares, par value $0.000006 per share ZLAB The Nasdaq Global Market
  • $41.1 million — of up to RMB300 million (approximately $41.1 million) (the "Loan Contract"). The credit faci
  • $137.0 million — s exceeding RMB1 billion (approximately $137.0 million), or increases in debt financings excee
  • $205.5 million — exceeding RMB1.5 billion (approximately $205.5 million). The description of the Guarantee and

Filing Documents

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. Zai Lab Limited (the "Company") identified an additional opportunity to access capital denominated in RMB through a debt facility with Bank of Communications on favorable commercial terms to support our working capital needs in mainland China. As a result, on January 2, 2025, the Company entered into a guarantee contract (the "Guarantee") with Bank of Communications Co., Ltd. Shanghai Zhangjiang Sub-Branch ("BOCOM") pursuant to which the Company will guarantee working capital loans from BOCOM to our wholly-owned subsidiary, Zai Lab (Shanghai) Co., Ltd. ("Zai Lab Shanghai"), and Zai Lab Shanghai entered into a working capital loan contract with BOCOM with respect to a revolving credit facility of up to RMB300 million (approximately $41.1 million) (the "Loan Contract"). The credit facility will be available until September 26, 2025, and key terms of the specific working capital loans, including the amount, term, and interest rate, will be included in the specific transaction documents. Each loan term will be up to 12 months, with a maturity date no later than March 26, 2026, and the interest rate will be initially determined based on the one-year loan prime rate ("LPR") immediately preceding the drawdown date minus 35 basis points and will be subject to adjustment every three months depending on the then one-year LPR. The Loan Contract contains customary representations and warranties and affirmative and restrictive covenants, including a requirement to obtain prior written consent from BOCOM before engaging in mergers, acquisitions, spin-offs, equity transfers, external investments or guarantees exceeding RMB1 billion (approximately $137.0 million), or increases in debt financings exceeding RMB1.5 billion (approximately $205.5 million). The description of the Guarantee and Loan Contract contained herein is qualified in its entirety by reference to the Guarantee, a copy of which is attached hereto as Exhibit 10.1

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1+ Unofficial English Translation of Guarantee Contract, dated as of January 2 , 202 5 , by and between Zai Lab Limited and Bank of Communications Co., Ltd. Shanghai Zhangjiang Sub-Branch 10.2+ Unofficial English Translation of Working Capital Loan Contract, dated as of January 2 , 202 5 , by and between Zai Lab (Shanghai) Co., Ltd. and Bank of Communications Co., Ltd. Shanghai Zhangjiang Sub-Branch 104 The cover page of this report is formatted in Inline XBRL + Portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZAI LAB LIMITED By: /s/ F. Ty Edmondson Name: F. Ty Edmondson Title: Chief Legal Officer and Corporate Secretary Date: January 3, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.